
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Novel 2-indolinone thiazole hybrids as sunitinib analogues: Design, synthesis, and potent VEGFR-2 inhibition with potential anti-renal cancer activity
Huda K. Mahmoud, Thoraya A. Farghaly, Hanan Gaber Abdulwahab, et al.
European Journal of Medicinal Chemistry (2020) Vol. 208, pp. 112752-112752
Closed Access | Times Cited: 67
Huda K. Mahmoud, Thoraya A. Farghaly, Hanan Gaber Abdulwahab, et al.
European Journal of Medicinal Chemistry (2020) Vol. 208, pp. 112752-112752
Closed Access | Times Cited: 67
Showing 1-25 of 67 citing articles:
Recent development of multi-target VEGFR-2 inhibitors for the cancer therapy
Xiujuan Liu, Hong-Cheng Zhao, Su-Juan Hou, et al.
Bioorganic Chemistry (2023) Vol. 133, pp. 106425-106425
Closed Access | Times Cited: 78
Xiujuan Liu, Hong-Cheng Zhao, Su-Juan Hou, et al.
Bioorganic Chemistry (2023) Vol. 133, pp. 106425-106425
Closed Access | Times Cited: 78
Novel sulfonyl thiazolyl-hydrazone derivatives as EGFR inhibitors: Design, synthesis, biological evaluation and molecular docking studies
Thoraya A. Farghaly, Eman M. H. Abbas, Amerah Alsoliemy, et al.
Bioorganic Chemistry (2022) Vol. 121, pp. 105684-105684
Closed Access | Times Cited: 44
Thoraya A. Farghaly, Eman M. H. Abbas, Amerah Alsoliemy, et al.
Bioorganic Chemistry (2022) Vol. 121, pp. 105684-105684
Closed Access | Times Cited: 44
Optimizing the Sunitinib for cardio-toxicity and thyro-toxicity by scaffold hopping approach
Bhagyashri Vijay Chaudhari, Harun Patel, Snehal Thakar, et al.
In Silico Pharmacology (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 39
Bhagyashri Vijay Chaudhari, Harun Patel, Snehal Thakar, et al.
In Silico Pharmacology (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 39
A comprehensive review on thiazole based conjugates as anti-cancer agents
Rupali Rana, Nitish Kumar, Harmandeep Kaur Gulati, et al.
Journal of Molecular Structure (2023) Vol. 1292, pp. 136194-136194
Closed Access | Times Cited: 27
Rupali Rana, Nitish Kumar, Harmandeep Kaur Gulati, et al.
Journal of Molecular Structure (2023) Vol. 1292, pp. 136194-136194
Closed Access | Times Cited: 27
Discovery of indolinone-bearing benzenesulfonamides as new dual carbonic anhydrase and VEGFR-2 inhibitors possessing anticancer and pro-apoptotic properties
Samaa Saied, Moataz A. Shaldam, Mostafa M. Elbadawi, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115707-115707
Closed Access | Times Cited: 24
Samaa Saied, Moataz A. Shaldam, Mostafa M. Elbadawi, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115707-115707
Closed Access | Times Cited: 24
Novel small molecule inhibitors targeting renal cell carcinoma: Status, challenges, future directions
Lin Xiong, Ya Zhang, Jiaxing Wang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116158-116158
Open Access | Times Cited: 13
Lin Xiong, Ya Zhang, Jiaxing Wang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116158-116158
Open Access | Times Cited: 13
Design, synthesis, and in vitro and in vivo anti-angiogenesis study of a novel vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitor based on 1,2,3-triazole scaffold
De-pu Wang, Kai-li Liu, Xinyang Li, et al.
European Journal of Medicinal Chemistry (2020) Vol. 211, pp. 113083-113083
Closed Access | Times Cited: 57
De-pu Wang, Kai-li Liu, Xinyang Li, et al.
European Journal of Medicinal Chemistry (2020) Vol. 211, pp. 113083-113083
Closed Access | Times Cited: 57
Discovery of novel indolyl-1,2,4-triazole hybrids as potent vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitors with potential anti-renal cancer activity
Sami A. Al‐Hussain, Thoraya A. Farghaly, Magdi E. A. Zaki, et al.
Bioorganic Chemistry (2020) Vol. 105, pp. 104330-104330
Closed Access | Times Cited: 52
Sami A. Al‐Hussain, Thoraya A. Farghaly, Magdi E. A. Zaki, et al.
Bioorganic Chemistry (2020) Vol. 105, pp. 104330-104330
Closed Access | Times Cited: 52
Design, synthesis and evaluation of novel thienopyrimidine-based agents bearing diaryl urea functionality as potential inhibitors of angiogenesis
Aram Faraji, Tayebeh Oghabi Bakhshaiesh, Zaman Hasanvand, et al.
European Journal of Medicinal Chemistry (2020) Vol. 209, pp. 112942-112942
Closed Access | Times Cited: 52
Aram Faraji, Tayebeh Oghabi Bakhshaiesh, Zaman Hasanvand, et al.
European Journal of Medicinal Chemistry (2020) Vol. 209, pp. 112942-112942
Closed Access | Times Cited: 52
Synthesis and biological evaluation of new derivatives of thieno-thiazole and dihydrothiazolo-thiazole scaffolds integrated with a pyrazoline nucleus as anticancer and multi-targeting kinase inhibitors
Ismail M. M. Othman, Zahra M. Al-Amshany, Nada Y. Tashkandi, et al.
RSC Advances (2021) Vol. 12, Iss. 1, pp. 561-577
Open Access | Times Cited: 52
Ismail M. M. Othman, Zahra M. Al-Amshany, Nada Y. Tashkandi, et al.
RSC Advances (2021) Vol. 12, Iss. 1, pp. 561-577
Open Access | Times Cited: 52
Recent advances in, and challenges of, anti-angiogenesis agents for tumor chemotherapy based on vascular normalization
Kai Wang, Qinhua Chen, Nanxin Liu, et al.
Drug Discovery Today (2021) Vol. 26, Iss. 11, pp. 2743-2753
Closed Access | Times Cited: 44
Kai Wang, Qinhua Chen, Nanxin Liu, et al.
Drug Discovery Today (2021) Vol. 26, Iss. 11, pp. 2743-2753
Closed Access | Times Cited: 44
Synthesis of a new series of pyrazolo[1,5-a]pyrimidines as CDK2 inhibitors and anti-leukemia
Samar J. Almehmadi, Amani M.R. Alsaedi, Marwa F. Harras, et al.
Bioorganic Chemistry (2021) Vol. 117, pp. 105431-105431
Closed Access | Times Cited: 43
Samar J. Almehmadi, Amani M.R. Alsaedi, Marwa F. Harras, et al.
Bioorganic Chemistry (2021) Vol. 117, pp. 105431-105431
Closed Access | Times Cited: 43
Discovery of novel thiazolyl-pyrazolines as dual EGFR and VEGFR-2 inhibitors endowed with in vitro antitumor activity towards non-small lung cancer
Esraa A. Abdelsalam, Amer Ali Abd El‐Hafeez, Wagdy M. Eldehna, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 2265-2282
Open Access | Times Cited: 38
Esraa A. Abdelsalam, Amer Ali Abd El‐Hafeez, Wagdy M. Eldehna, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 2265-2282
Open Access | Times Cited: 38
Rationale design, synthesis, cytotoxicity evaluation, andin silicomechanistic studies of novel 1,2,3-triazoles with potential anticancer activity
Esraa M. Othman, Eman A. Fayed, Ebtehal M. Husseiny, et al.
New Journal of Chemistry (2022) Vol. 46, Iss. 25, pp. 12206-12216
Closed Access | Times Cited: 32
Esraa M. Othman, Eman A. Fayed, Ebtehal M. Husseiny, et al.
New Journal of Chemistry (2022) Vol. 46, Iss. 25, pp. 12206-12216
Closed Access | Times Cited: 32
Novel VEGFR‐2 Kinase Inhibitors as Anticancer Agents: A Review Focusing on SAR and Molecular Docking Studies (2016–2021)
S. Vishakha, Kumari Kajal, Sitanshu Mondal, et al.
Chemistry & Biodiversity (2023) Vol. 20, Iss. 2
Closed Access | Times Cited: 17
S. Vishakha, Kumari Kajal, Sitanshu Mondal, et al.
Chemistry & Biodiversity (2023) Vol. 20, Iss. 2
Closed Access | Times Cited: 17
Unraveling the Promise of RET Inhibitors in Precision Cancer Therapy by Targeting RET Mutations
Zixuan Wang, Qingqing Li, Jiao Cai, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 6, pp. 4346-4375
Closed Access | Times Cited: 8
Zixuan Wang, Qingqing Li, Jiao Cai, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 6, pp. 4346-4375
Closed Access | Times Cited: 8
Design, synthesis and evaluation of anticancer activity of new pyrazoline derivatives by down-regulation of VEGF: Molecular docking and apoptosis inducing activity
Rasha A. Hassan, Soha H. Emam, Dukhyun Hwang, et al.
Bioorganic Chemistry (2021) Vol. 118, pp. 105487-105487
Closed Access | Times Cited: 33
Rasha A. Hassan, Soha H. Emam, Dukhyun Hwang, et al.
Bioorganic Chemistry (2021) Vol. 118, pp. 105487-105487
Closed Access | Times Cited: 33
Anti-viral activity of thiazole derivatives: an updated patent review
Thoraya A. Farghaly, Amani M.R. Alsaedi, Noof A. Alenazi, et al.
Expert Opinion on Therapeutic Patents (2022) Vol. 32, Iss. 7, pp. 791-815
Closed Access | Times Cited: 28
Thoraya A. Farghaly, Amani M.R. Alsaedi, Noof A. Alenazi, et al.
Expert Opinion on Therapeutic Patents (2022) Vol. 32, Iss. 7, pp. 791-815
Closed Access | Times Cited: 28
Synthesis and molecular docking simulation of new benzimidazole–thiazole hybrids as cholinesterase inhibitors
Dina H. Dawood, Aladdin M. Srour, Mohamed A. Omar, et al.
Archiv der Pharmazie (2023) Vol. 357, Iss. 1
Closed Access | Times Cited: 14
Dina H. Dawood, Aladdin M. Srour, Mohamed A. Omar, et al.
Archiv der Pharmazie (2023) Vol. 357, Iss. 1
Closed Access | Times Cited: 14
Novel quinazolines bearing 1,3,4-thiadiazole-aryl urea derivative as anticancer agents: design, synthesis, molecular docking, DFT and bioactivity evaluations
Sara Masoudinia, Marjaneh Samadizadeh, Maliheh Safavi, et al.
BMC Chemistry (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 5
Sara Masoudinia, Marjaneh Samadizadeh, Maliheh Safavi, et al.
BMC Chemistry (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 5
Discovery of novel benzimidazole derivatives as potent HDACs inhibitors against leukemia with (Thio)Hydantoin as zinc-binding moiety: Design, synthesis, enzyme inhibition, and cellular mechanistic study
Hanan Gaber Abdulwahab, Reda El‐Sayed Mansour, Thoraya A. Farghaly, et al.
Bioorganic Chemistry (2024) Vol. 146, pp. 107284-107284
Closed Access | Times Cited: 5
Hanan Gaber Abdulwahab, Reda El‐Sayed Mansour, Thoraya A. Farghaly, et al.
Bioorganic Chemistry (2024) Vol. 146, pp. 107284-107284
Closed Access | Times Cited: 5
Emerging Importance of Tyrosine Kinase Inhibitors against Cancer: Quo Vadis to Cure?
Raj Kumar Mongre, Chandra Bhushan Mishra, Arvind Kumar Shukla, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11659-11659
Open Access | Times Cited: 29
Raj Kumar Mongre, Chandra Bhushan Mishra, Arvind Kumar Shukla, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11659-11659
Open Access | Times Cited: 29
Fluorinated azole anticancer drugs: Synthesis, elaborated structure elucidation and docking studies
Amani M.R. Alsaedi, Thoraya A. Farghaly, Mohamed R. Shaaban
Arabian Journal of Chemistry (2022) Vol. 15, Iss. 5, pp. 103782-103782
Open Access | Times Cited: 21
Amani M.R. Alsaedi, Thoraya A. Farghaly, Mohamed R. Shaaban
Arabian Journal of Chemistry (2022) Vol. 15, Iss. 5, pp. 103782-103782
Open Access | Times Cited: 21
New thiophene, thienopyridine and thiazoline-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents and multitargeting kinase inhibitors
Zahra M. Al-Amshany, Nada Y. Tashkandi, Ismail M. M. Othman, et al.
Bioorganic Chemistry (2022) Vol. 127, pp. 105964-105964
Closed Access | Times Cited: 21
Zahra M. Al-Amshany, Nada Y. Tashkandi, Ismail M. M. Othman, et al.
Bioorganic Chemistry (2022) Vol. 127, pp. 105964-105964
Closed Access | Times Cited: 21
Synthesis of antimicrobial azoloazines and molecular docking for inhibitingCOVID ‐19
Zeinab A. Muhammad, Thoraya A. Farghaly, Ismail Althagafi, et al.
Journal of Heterocyclic Chemistry (2021) Vol. 58, Iss. 6, pp. 1286-1301
Open Access | Times Cited: 27
Zeinab A. Muhammad, Thoraya A. Farghaly, Ismail Althagafi, et al.
Journal of Heterocyclic Chemistry (2021) Vol. 58, Iss. 6, pp. 1286-1301
Open Access | Times Cited: 27